GeneFluidics Inc.
GeneFluidics Inc. (GeneFluidics) is a privately held novel technology company. The company is principally engaged in commercialization of a novel molecular analysis platform that integrates bionanotechnology and microfluidics. The platform has two distinct and synergistic components namely electrochemical detection, which is embedded in a multichannel reader and plastic sensor chips, and automated sample preparation that is embedded in microfluidic cartridges and associated with reader fluidic controls. By the integration of these two components, the rapid detection and quantification of genetic material is possible. By using this platform, the complex tests can be done by skilled technicians in a laboratory. The product portfolio of the company includes proteus and asklepios. GeneFluidics is headquartered at Monterey Park in California, the US.
Company Index Score
| Current Index Score | Historical Index Score |
![]() |
|
| |
Latest tweets
More from New Statesman
- Online writers:
- Steven Baxter
- Rowenna Davis
- David Allen Green
- Mehdi Hasan
- Nelson Jones
- Gavin Kelly
- Helen Lewis
- Laurie Penny
- The V Spot
- Alex Hern
- Martha Gill
- Alan White
- Samira Shackle
- Alex Andreou
- Nicky Woolf in America
- Bim Adewunmi
- Glosswitch
- Kate Mossman on pop
- Ryan Gilbey on Film
- Martin Robbins
- Rafael Behr
- Eleanor Margolis
- Tools and services:
- Polls
- Predictions
- Archive
- Magazine
- PDF edition
- RSS feeds
- Advertising
- Subscribe
- Special supplements
- Stockists

